Log in to search using one of your social media accounts:


PhRMA, member companies and NIH create public-private partnership for immuno-oncology

The rapid pace of scientific advances has helped usher in anew era of medicine for cancer patients over the last decade. This morning, the National Institutes of Health (NIH) took asignificant step in advancing this new era by partnering with PhRMA and nine of its member companies to create the Partnership for Accelerating Cancer Therapies (PACT), a five-year research collaboration totaling $215 million as part of the Cancer Moonshot initiative. This public-private partnership will be managed by the Foundation for the National Institutes of Health.
Source: The Catalyst - Category: Pharmaceuticals Tags: Research and Development cancer Source Type: news

Related Links:

More News: Cancer | Cancer & Oncology | Cancer Therapy | National Institutes of Health (NIH) | Partnerships | Pharmaceuticals